-
Immune and Metabolic Reprogramming Induced by Paclitaxel, Capecitabine and Eribulin in Breast Cancer: Insights into Therapeutic Targets
28 Apr 2025 17:19 GMT
… pharmacologic interventions: eribulin, capecitabine and paclitaxel (Figure … Resistance to Eribulin, Capecitabine and Paclitaxel results … progression on eribulin, capecitabine and paclitaxel, respectively. … with non-small cell lung cancer. Clin Transl Oncol …
-
Cancer Patients’ Behavior and Perception on the Use of Medical Foods and Dietary Supplements During Chemotherapy
09 May 2025 10:21 GMT
… cyclophosphamide), anti-metabolite-based regimens (capecitabine with oxaliplatin or irinotecan, 5 … intakes in non-small cell lung cancer patients receiving chemotherapy. Thai JPEN …
-
Puma Biotechnology Reports First Quarter Financial Results
08 May 2025 20:15 GMT
… with extensive stage small cell lung cancer (H2 2025).”
Revenue
Total revenue … -based therapy.
In combination with capecitabine, for the treatment of adult … infection.
NERLYNX in combination with capecitabine: diarrhea, nausea, vomiting, decreased appetite …
-
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
06 May 2025 21:41 GMT
… the FDA in combination with capecitabine for the treatment of adult … the treatment of small cell lung cancer and breast cancer. In February … with extensive-stage small cell lung cancer. In November 2024, Puma initiated …
-
Real-World Data, Real-Time Decisions: AI at the Front Lines of Oncology
02 May 2025 19:19 GMT
… complicated regimens, like, for example, [capecitabine and temozolomide] for neuroendocrine carcinomas … stage IV non–small cell lung cancer, I would want a relatively …
-
Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer
03 Jun 2024 18:48 GMT
… advanced osimertinib-resistant EGFR-mutated lung cancer,” was presented by Turja Chakrabarti … the FDA in combination with capecitabine for the treatment of adult … with extensive-stage small cell lung cancer.
Further information about Puma Biotechnology …
-
Bevacizumab by F. Hoffmann-La Roche for Small-Cell Lung Cancer: Likelihood of Approval
17 May 2024 03:08 GMT
… Avastin in combination with xeloda or paclitaxel is indicated … squamous non-small cell lung cancer (with carboplatin and … carcinoma, non-small cell lung cancer, metastatic colorectal cancer, … adjuvant non small cell lung cancer (NSCLC), metastatic liver …
-
Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for Breast Cancer Patients
30 Apr 2025 10:00 GMT
… use with a medicine called capecitabine to treat adults with … the FDA in combination with capecitabine for the treatment of … the treatment of small cell lung cancer and breast cancer. In … with extensive-stage small cell lung cancer. In November 2024, Puma …
-
Two Datopotamab Deruxtecan Applications Validated in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer or HR Positive, HER2 Negative Breast Cancer
04 Mar 2024 10:29 GMT
… nonsquamous non-small cell lung cancer (NSCLC) who … -agent chemotherapy (eribulin, capecitabine, vinorelbine or gemcitabine) … Small Cell Lung Cancer
Nearly 500,000 lung cancer cases were … References:
1 Cancer.net. Lung Cancer – Non-Small Cell: Statistics …
-
Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware
29 Apr 2025 10:57 GMT
… complete resection.
Non-Small Cell Lung Cancer
KEYTRUDA, in combination with pemetrexed … metastatic nonsquamous non-small cell lung cancer (NSCLC), with no EGFR or … combination with trastuzumab and CAPOX (capecitabine plus oxaliplatin) or FP (5 …
About
© 1995-2025